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Abstract
Background: People with type 1 diabetes (T1D) undertake self-management to prevent short and long-term complications.
Advanced technology potentially supports such activities but requires consideration of psychological and behavioral constructs
and usability issues. Economic factors and health care provider capacity influence access and uptake of advanced technology.
Previous reviews have focused upon clinical outcomes or were descriptive or have synthesized studies on adults with those on
children and young people where human factors are different.
Objective: This review described and examined the relationship between human factors and adherence with technology for
data logging processes in adults with T1D.
Methods: A systematic literature search was undertaken by using the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. Quality appraisal was undertaken and data were abstracted and categorized into the themes
that underpinned the human factor constructs that were examined.
Results: A total of 18 studies were included. A total of 6 constructs emerged from the data analysis: the relationship between
adherence to data logging and measurable outcomes; satisfaction with the transition to advanced technology for self-management;
use of advanced technology and time spent on diabetes-related activities; strategies to mediate the complexities of diabetes and
the use of advanced technology; cognition in the wild; and meanings, views, and perspectives from the users of technology.
Conclusions: Increased treatment satisfaction was found on transition from traditional to advanced technology use—insulin
pump and continuous glucose monitoring (CGM); the most significant factor was when blood glucose levels were consistently
<7.00 mmol/L (P ≤.01). Participants spent considerable time on their diabetes self-care. Logging of data was positively correlated
with increasing age when using an app that provided meaningful feedback (regression coefficient=55.8 recordings/year; P ≤.01).
There were benefits of CGM for older people in mediating complexities and fears of hypoglycemia with significant differences
in well-being (P ≤.001). Qualitative studies explored the contextual use and uptake of technology. The results suggested frustrations
with CGM, continuous subcutaneous insulin infusion, calibration of devices, and alarms. Furthermore implications for “body
image” and the way in which “significant others” impacted on the behavior and attitude of the individual toward technology use.
There were wide variations in the normal use of and interaction with technology across a continuum of sociocultural contexts,
which has implications for the way in which future technologies should be designed. Quantitative studies were limited by small
sample sizes, making it difficult to generalize findings to other contexts. This was further limited by a sample that was predominantly
white, well-controlled, and engaged with self-care. The use of critical appraisal frameworks demonstrated where research into
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human factors and data logging processes of individuals could be improved. This included engaging people in the design of the
technology, especially hard-to-reach or marginalized groups.
(JMIR Hum Factors 2018;5(1):e11)   doi:10.2196/humanfactors.9049
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Introduction
Personal decision-making and human factors
Individuals with type 1 diabetes (T1D) are confronted with
complex tasks through which to manage their blood glucose
(BG) levels. T1D is an autoimmune disease where the beta cells
in the pancreas no longer produce insulin, resulting in
dangerously high BG levels or hyperglycemia. The person
diagnosed with T1D is subsequently required to self-administer
insulin. This involves regular self-monitoring of BG levels and
calculation of appropriate insulin doses. There is a delicate
balance between the reductions of the risks of long-term
complications (often associated with hyperglycemia) and those
of hypoglycemic events. This puts emphasis on adherence and
patient behaviors. It has been suggested that large numbers of
people with T1D are nonadherent [1]. Additionally, Patton [2]
highlights multiple social, emotional, and cognitive barriers.
The prevalence of new and emergent technologies to support
self-management of T1D through personal data logging
processes and support for decision making may have the
potential to address these issues.
There may be a dilemma for health care providers due to the
economic implications of adopting such technologies for
individuals compared with potential public health benefits. This
raises the issue of identification of adults with T1D who may
benefit the most. There are associated questions around how to
investigate and evaluate the benefits of such technology with
respect to specific populations in such a way as to inform future
design decisions. Thus, consideration of psychological and
behavioral constructs alongside evaluation of the usability of
devices, also known as human factors, is an integral component
of any investigation that involves clinical consideration for
emergent technology aimed at self-management of T1D.
The objective of this review was to describe the relationship
between human factors and technology adherence for data
logging processes in adults with T1D and to explore the factors
that influence this association.
Background
Advanced Technology for Self-Management of Type 1
Diabetes
The potential for technology to support individuals with T1D
is increasing rapidly. The following overview covers general
principles where the individual interacts with the technology to
log his or her personal data in some capacity.
Continuous glucose monitoring (CGM) provides information
regarding changes in glucose concentrations within interstitial
fluid in real time. The corresponding device consists of a sensor,
which is placed in the subcutaneous tissue, and a monitor, which
may or may not be connected wireless. CGM data are used
either to assist with retrospective decision making by a clinician
or to support individual self-management. There is potential for
an abundance of information about trends and directions in BG
levels, including fluctuations over time for retrospective analysis
[3]. One of the motivations for development of CGM is to
recognize nocturnal hypoglycemia; another is to support people
who may have lost their hypoglycemic awareness [4].
Real-time CGM has been available from 2005, and since then,
advances in technology have improved the accuracy of CGM
systems and provide potential advantages in terms of relaying
the glucose history of an individual. Castle and Jacobs [5]
suggest that there is valid evidence that both hyperglycemia and
hypoglycemia are reduced with consistent CGM use. The
optimal way to adjust insulin doses is complex, and there is
little guidance for individuals about how to interpret the data.
Internationally, there is low uptake of CGM but that may say
more about availability and access than about the wishes of
individuals.
Most individuals with T1D administer insulin via multiple daily
injections (MDI), but some use an insulin pump that delivers
bolus doses of insulin on demand of the user in addition to tiny
amounts of insulin. These are administered every few minutes
but may vary at different times of the day, thereby delivering
what is known as continuous subcutaneous infusion of insulin
(CSII). Advantages may include not physically injecting each
delivered bolus dose and the availability of more physiologic
basal insulin than available long-acting insulins can provide,
and it is not necessary to inject each time a dose is administered.
Theoretically, the way in which doses may be tailored is more
specific to the insulin requirements of the individual [3]. There
are 2 types of insulin pumps. One is tethered to a cannula that
enters the subcutaneous tissues. This means that the pump must
be worn by the user and may be visible. A patch pump on the
other hand consists of a short tube attached to a cannula with
an integrated micropump that is controlled wirelessly by the
user [3], which can be hidden.
Sensor-augmented pump therapy (SAPT) is the concurrent
application of real-time CGM with an insulin pump. However,
this does not lead to automatic insulin adjustment. It is
incumbent on the user to use adjunctive self-monitoring of BG
and make dose adjustments to suit his or her own insulin
requirements. Future developments include decision-support
systems that will recommend insulin doses based on an array
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of factors, including historical data of the individual, and will
also connect to health care providers.
Closed loop systems are sometimes known as artificial pancreas
and manage insulin delivery in response to real-time CGM data,
which is controlled by algorithms rather than preprogrammed
rates [6]. According to Castle and Jacobs [5], this can also
include delivery of glucagon to raise BG levels when necessary.
Apps run on mobile devices such as mobile phones and tablets
and perform functions previously restricted to personal
computers. Those designed specifically for people with T1D
can generally be categorized into 5 areas:
1. Glucose tracking diaries
2. Carbohydrate estimators
3. Recipe planners
4. Medication adherence tools
5. Diabetes education platforms [7]
Telehealth refers to logging of health care data by the patient,
which is tracked by health care professionals (HCPs) at a
distance [8]. For example, the use of mobile devices by the
patient enables any time, any place, anywhere logging and
transmission of data.
Access, Uptake, and Current Limitations
Access and uptake of advanced technology, such as CGM and
CSII, are controlled by health care economies and clinical policy
guidelines. For example, in 2011, it was estimated that uptake
may be between 20% and 30% in the United States and Israel
compared with 1% in Denmark [9].
Acerini [10] claims that, even if CGM and CSII were readily
available, those who could benefit the most from use would not
access it and that diabetes technology uptake is lower in some
ethnic groups. Furthermore, adoption is governed by
socioeconomic status and cultural factors in addition to access
to appropriate health care services. Crucially, health care
practitioners’ willingness and capacity to support patient access
are other critical factors [11].
To date, most research into use of advanced technology has
focused on the clinical outcomes, which overall are equivocal
[9,10,12]. Kerr and Partridge [6] critique the endpoints of
previous clinical trials, which focus purely on glycated
hemoglobin (HbA1c) levels without reference to other outcomes
that may be equally meaningful to adults with T1D.
Transition and use of advanced technologies require training
and physical and psychological adaptation by the users and their
families. Human factors are, therefore, an essential component
in reaching a better understanding of uptake and use of
technology and in informing design decisions.
Human Factors and Type 1 Diabetes
There are differential aspects of the human factor that affect the
use of technology in diabetes self-management [13]. These may
be conceptualized as follows:
1. Behavioral
• Barriers to adherence [2]
• Demands of the technology, which may especially
affect motivation to undertake regular self-management
tasks [1,14]
• Time spent on diabetes therapy tasks [11]
2. Psychological
• Adjustment to diabetes [15]
• Fear of hypoglycemia [11,14,16]
• The emotional implications of increased responsibility
for self-management including fear of disapproval by
HCPs and worthiness to receive cutting-edge treatment
[17]
• Self-belief, impact on quality of life, reactions of others,
unconscious motives based on earlier experiences [18]
• Trust in the technology, letting go of prior routines
[11,17]
• Depression and eating disorders [18]
3. Social
• Wearability of devices and body image [11]
• Interpersonal relationships and working out how to
handle interactions with others and when and how to
disclose the condition [18]
• Support from significant others to engage with
technology [9]
• Choice about whom to share data with [11]
• Stigma surrounding the carrying out of tasks in social
situations [4]
4. Cognitive
• Educational needs, such as that of learning how to use
the technology and utilize greater knowledge of
personal glucose trends to make dosing decisions [9]
• Additional learning associated with the use of
technology [19]
• Health literacy and associated embarrassment with low
literacies [20]
• Reduced cognitive abilities associated with age and
adult level of educational attainment [21]
Current research in the field of advanced technology for diabetes
has emerged from different disciplines, for example, health care
practice, psychology, computer science, electronic engineering,
and related industries. To reach a full understanding, it is crucial
to bring this research together in a systematic way. Previous
reviews have focused on clinical outcomes alone [5,22], have
descriptively scoped the literature [13,23], or have synthesized
studies on children and young people with studies on adults
[24] where the needs for technology and associated human
factors are likely to be different. Thus, there is a gap for a review
that systematically appraises current research on the relationship
between human factors and data logging processes with
advanced technologies for adults with T1D.
Aims of the Review
The aim of this systematic review was to describe the
relationship between human factors and adherence with
technology for data logging processes in adults with T1D and
to explore the factors that influence this association.
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An integrative literature review research design was chosen
because it provides a more holistic conceptualization on a
complex topic [25] such as human behavior and facilitates
inclusion of diverse methodologies and theories, given the
interdisciplinary approach toward research in the field.
A protocol was developed (Multimedia Appendix 1) to clarify
the aims, sampling strategy, exclusion and inclusion criteria,
methods, outcomes, language, and search strategy.
Methods
Literature Search
A systematic search of the literature was performed in
accordance with the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) [26] in January to March
of 2017 (Multimedia Appendix 2)
The following databases were searched: Computing Research
Repository (2006 to January 2017); PsycINFO, EMBASE, and
MEDLINE (2006 to January 2017); Web of Science (2006 to
January 2017); Zetoc (2006 to January 2017); Excerpta Medica
and Scopus (2006 to January 2017); and ProQuest (2006 to
January 2017). Only research that was undertaken during the
last 10 years was included as technology for the
self-management of T1D has been developing rapidly during
this time. Search terms included: Diabet* AND Techno* AND
Behavi*; Self-manage* OR self-manage* OR manage* OR
self-care OR self-care; technolog* OR telehealth OR
telemedicine OR reminder system* OR text messag* OR
application OR app*; adhere* OR compliance OR barrier OR
problem* OR obstacle: MH Diabetes Mellitus, Type 1*.
Searches were limited to adults (over 18 years) and filtered to
studies of adults published in English. Reference lists were also
searched in addition to subject-specific websites and key journals
(Multimedia Appendix 1). The search strategy was carried out
in collaboration with a university health care librarian.
Unpublished studies (dissertations and theses) were excluded,
in addition to editorials, opinions, and discussion papers. Studies
were reviewed for the following criteria: (1) primary research;
(2) empirical data on adherence to data logging processes with
the use of advanced technology for adults with T1D; (3) an
investigation of the relationship with psychological, social, and
human factors; and 4) the psychological outcome measures were
explicit (quantitative studies) or alternatively included a clearly
described picture of the phenomenon that included the user
perspective (qualitative studies).
Search Outcomes
The search strategy produced 1 article in the Computing
Research Repository; 348 articles in PsycINFO, EMBASE, and
MEDLINE; 40 articles in the Web of Science; 84 articles in
Zetoc; 38 articles in Excerpta Medica and Scopus; and 36
articles in ProQuest. Once duplicates were removed, additional
articles were excluded due to limitations associated with unclear
abstracts or for not meeting the inclusion criteria (ie, children,
type 2 diabetes, and gestational diabetes). In total, 72 citations
were retained and each abstract was read for relevance.
Also, 3 citations were found from searching reference lists and
key journals. One study, which included children and their
carers, was retained because outcomes were compared with
adults who also participated within the study [27]. To reduce
bias and ensure that only the most relevant articles were selected,
the second and third authors reviewed the titles and abstracts
regarding the protocol criteria and a consensus was reached
about the articles to be included in the review. In total, 22
articles met the inclusion criteria, and these included 14
quantitative studies, 5 qualitative studies, and 3 mixed-method
studies (Multimedia Appendix 2).
Quality Appraisal
Whittemore and Knafl’s approach [25] of using as many
instruments as necessary to evaluate the quality of the data was
taken because this is an integrative review, and the data are
drawn from more than one disciplinary area that use a range of
research traditions that align with quantitative, qualitative, or
mixed-method research designs. The instruments for appraisal
were selected from the University of South Australia
International Centre for Allied Health Evidence [28] databases
of critical appraisal tools. The following criteria were taken into
consideration for types of study design: demographic
information of the participants and statement of research
question, appropriateness of the research question for the
selected study design, and approach to recruitment reported
(Table 1). The criteria for quantitative study designs included
power analysis reported response rate, reliability and validity
of study instruments and method of data analysis (Table 2). The
following criteria were considered for qualitative studies:
theoretical perspectives, audit trail, member checks, peer review
of qualitative data, and method of data analysis (Table 3). The
first author undertook the quality appraisal of each study, which
was peer-reviewed independently by second and third authors.
Following the critical appraisal process, 4 studies were further
excluded for poor methodological design.
Data Abstraction and Analysis
The review data were categorized and synthesized into the
themes that underpinned the human constructs that were
examined and the outcomes that were reported. Mile and
Huberman’s [46] approach to coding of data, which involves
data reduction and comparison, was utilized.
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Table 1. Quality appraisal.
Approach to recruitment
reported
Demographic information
of participants
Aptness of study design for
research aims
Type of study designAuthor
YesYesNoObservationalGroat et al [29]
YesYesYesObservationalGonder-Frederick et al [30]
YesYesYesObservationalSkrosveth et al [31]
YesYesYesRandomized controlled trialTansey et al [27]
YesYesYesRandomized controlled trialKamble et al [32]
Not reportedYesYesRandomized controlled trialMartinez- Sarrigui et al [33]
YesYesYesLongitudinal cohort studyGonzalez- Molero et al [34]
YesYesYesRandomized controlled trialKirwan et al [35]
YesYesYesCross-sectionalPolonsky et al [36]
YesYesYesCross-sectionalBarnard et al [37]
YesYesYesCross-sectionalNaranjo et al [38]
YesYesYesCross-sectionalBorges and Kubiak [39]
YesYesYesQualitativeShepherd et al [40]
YesYesYesQualitativeRitholz et al [41]
YesYesYesEthnographyO’Kane et al [42]
YesYesYesEthnographyStorni [43]
YesYesYesQualitativeLawton et al [44]
YesYesYesMixed methodsBarnard et al [45]
Table 2. Quality appraisal quantitative studies .
Method of data analysisReliability and validity of
study instrument established
Response rate (%)Power calculation reportedAuthor
Correlation analysisNoNot reportedNoGroat et al [29]
Analysis of covarianceYcNot reportedNoGonder-Frederick et al [30]
Regression analysisNoNot reportedNoSkrosveth et al [31]
Correlation analysisYesNot reportedNoTansey et al [27]
Correlation analysisYesNot reportedNoKamble et al [32]
Regression analysisNoNot reportedNoMartinez-Sarrigui et al [33]
Correlation analysisYesNot reportedNoGonzalez-Molero et al [34]
Regression analysisYesNot reportedYesKirwan et al [35]
Regression analysisNo48.6NoPolonsky et al [36]
Correlation analysisNo96.7NoBarnard et al [37]
Correlation analysisYesNot reportedNoNaranjo et al [38]
Factor analysisYesNot reportedNoBorges and Kubiak [39]
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Table 3. Quality appraisal of qualitative research.
Method of data analysisPeer review of qualitative dataMember checksAudit trailTheoretical perspectiveAuthor
Thematic analysisNot reportedNot reportedYesNot reportedShepherd et al [40]
Thematic analysisYesYesYesBiophysical model of
glycemic control in diabetes
Ritholz et al [41]
Thematic analysisNot reportedNot reportedYesSociocultural theoryO’Kane et al [42]
Thematic analysisNot reportedNot reportedYesEthnomethodologyStorni [43]
Thematic analysisYesYesYesNot reportedLawton et al [44]
Results
The 18 studies included in this review consist of 5 qualitative
studies [40-44], 5 experimental studies [27,32-35], 3
observational studies [29-31], 4 cross-sectional studies [36-39],
and 1 mixed-methods study [45]. Of the studies, 5 were smaller
samples drawn from parent clinical trials [30,32,38,40,41].
The total number of participants who were included in the 18
studies was 3320 and the mean age was 42 years, although one
study [36] specifically recruited people over the age of 65 years.
Female participants represented 53% of the sample. The mean
prebaseline HbA1c was 7.9% (where reported).
Multimedia Appendix 3 summarizes the type of technology
included in the review and the human factor constructs and
outcomes that were examined.
After categorization and synthesis of themes, 6 overall constructs
emerged:
1. The relationship between adherence to data logging and
measurable outcomes
2. Satisfaction with the transition to advanced technology for
self-management
3. Use of advanced technology and time spent on
diabetes-related activities
4. Strategies to mediate the complexities of diabetes and the
use of advanced technology
5. Cognition in the wild
6. Meanings, views, and perspectives from the users of
technology
The Relationship Between Adherence to Data Logging
and Measurable Outcomes
There was inconclusive evidence about the relationship between
adherence to data logging process and measurable outcomes.
For example, Kirwan et al [35] examined a freely available iOS
app—Glucose Buddy—combined with text messaging feedback
from a diabetes educator aimed at the improvement of glycemic
control. The intervention group showed a significant decrease
in HbA1c (mean −1.10; SD 0.74; (P ≤.001) over the 9-month
period of the study; however, linear regression showed no
significant relationship between the level of engagement with
the app and these outcomes. This result may be interpreted with
caution, given the small sample size (n=27). Furthermore, there
was a potential socioeconomic bias in that participants were
required to have iOS ownership.
Groat et al [29] analyzed individual participant internet protocol
address data to characterize the relationship between adherence
to insulin bolus dosing, logging of carbohydrate intake, and BG
monitoring and glycemic control for a 1-month period. The only
significant outcome was that an increase in daily insulin bolus
doses had an impact on increasing the number of days that the
BG was at target (r=.93). The reported results were based upon
an extremely small sample (n=8) and described as regression
analysis, which contradicts the researchers’ claims for
undertaking a qualitative study.
Satisfaction With Transition to the Use of Advanced
Technology for Self-Management
Some findings suggest that adults with T1D may feel more
satisfied with their treatment on transition to advanced
technology. For example, Gonzalez et al [34] evaluated the
overall effect of adding a telemedicine system for adults with
T1D who were treated with an insulin pump and real-time CGM.
This was a longitudinal study that measured the physical and
psychological outcomes of the intervention. Mean plasma HbA1c
was significantly lower at 6 months compared with prebaseline
(6.97 vs 7.5; P=.01); there was a significant reduction in glucose
variability at 6 months compared with baseline (53.1 vs 68.7;
P=.04) and prebaseline (53.1 vs 67.3; P=.04), and time spent
interacting with the sensor correlated positively with time in
normoglycemia (r=.72; P=.03) and negatively with occurrences
of mild hypoglycemia (r=.64; P=.02). From a psychological
perspective, there was an improvement in quality of life scores
at 6 months in comparison with baseline (92.4 vs 86.9; P=.01),
and participants with poorer glycemic control had significant
improvements with prior dissatisfaction with treatment (34.3
vs 31.6; P=.01).
The authors acknowledged that the findings were based on a
small sample size (n=15), and therefore, it is not possible to
generalize the outcomes. The authors also questioned whether
the point of being observed affected the outcome measures.
However, the study did show that there may be benefits for
well-controlled individuals using CGM in conjunction with
telemetry in terms of HbA1c and quality of life as reported in
the previous paragraph.
There is some consistency regarding the perceived physical
outcomes and satisfaction of the above study with the findings
of Barnard et al [45], who measured the relationship between
satisfaction when transitioning to the then-current insulin pumps
(Animas Vibe CGM-enabled system IV) and personal glycemic
control. The most significant contributing factor to treatment
satisfaction was when BG levels were consistently <7.00
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mmol/L (P=.009). The limits of this study are that the findings
are based on self-report, and it is not clear why only 22 items
of the 50 on the Insulin treatment satisfaction questionnaire
were included on the survey instrument.
Use of Advanced Technology and the Relationship
With Time Spent on Device-Related Activities
Frequent users of existing diabetes technology may find an
easier transition to more advanced options. For example, Tansey
et al [27] examined the perceived barriers and benefits to CGM
use and how this related to frequency of use. Engaged CGM
users were more satisfied, with higher frequency users less
bothered by the “hassles” of the device. Frequent users were
classified as engaged with CGM for more than 6 days per week
and infrequent users less than 4 days per week. Adults and
parents of users had higher total and subscale scores on the
CGM satisfaction survey (P=.0009). All respondents reported
that visualization of glucose trends and the opportunity to detect
hypoglycemia were the best aspects of use of CGM (text item
responses in the questionnaire).
Martinez-Sarriegui et al [33] analyzed patient behavior when
using the intervention of telemedicine system combined with
CGM to identify how the CGM data captured participant
interactions with the mobile system. In 2 phases of the
experiment (with and without the telemedicine system),
participants were provided with tools for visualization,
management of monitoring data, and wireless downloading of
data from an insulin pump via a personal smart assistant running
on a personal digital device. The number of times interacting
with the system was higher during the intervention phase (29.0
vs 18.8; P=.04), and the total time spent interacting with the
system was also higher during the intervention phase (04:27:11
vs 01:47:07; P=.009).
Kamble et al [32] compared weekly estimates of time, changes
in time, and patient time costs associated with diabetes-related
care between SAPT and MDI. They used data on
patient-reported time collected over a 52-week period.
Participants were required to log the total time spent per week
on diabetes management for a range of diabetes-related
variables. The total time spent on the SAPT arm of the study
was higher than time spent on MDI during and after pump
initiation within the overall 52-week study. The reported weekly
time estimates were as follows: SAPT 4.4 hours and MDI 3.4
hours (95% CI 0.4-1.7). However, all adults with T1D in the
study reported that they spend considerable time on diabetes
care.
Each of the above 3 studies suggests that engagement with
technology is time consuming. Given that the inclusion criteria
for the Tansey et al [27] study were prior high frequency of
self-monitoring, it is not clear if the technology was a mediating
factor for engagement. The Martinez-Sarriegui et al [33] study
was limited by a small sample size (n=10) and did not include
any details about how the study instrument was developed or
how the participants valued the feedback from the telemedicine
system. Furthermore, there was a possibility for margin of error
with the Kamble et al [32] study as it was not clear how
participants measured time costs.
Strategies to Mediate the Complexities of Diabetes and
the Use of Advanced Technology
Some researchers have attempted to understand the way in which
the human complexities of diabetes have the potential to be
mediated with the use of advanced technology.
Meaningful Feedback for the User
Skrosveth et al [31] explored which methods of diabetes data
analysis could be realistically used to provide meaningful
feedback for the user. A mobile diary app was developed for
adults with T1D to log insulin doses and dietary intake with
options for the user to comment upon these and a screen to
visualize each of the following variables: BG level, insulin
dosing, and dietary intake. Retrospectively, the sample was
divided into 2 groups: “adopters” (n=18), who reliably logged
data for at least 80 days, and nonadopters (n=12), who did not.
Logging of data was positively correlated with increasing age
(regression coefficient=55.8 recordings per year; P ≤.007), but
the usage did not significantly correlate with prestudy HbA1c
(P=.33) or gender (P=.09). The researchers also found that
several methods of pattern recognition were unable to predict
future BG values. The study was limited by lack of demographic
information about the participants and how they were recruited.
More information about nonadopters such as confounding
variables would have increased the reliability and validity of
the results.
Engaging Older Adults With Continuous Glucose
Monitoring
Polonsky et al [36] surveyed 2 groups of participants aged 65
years and older with T1D to determine differential characteristics
between users of real-time CGM and nonusers (hopefuls). CGM
hopefuls reported a higher incidence of 1 moderate
hypoglycemic episode in the preceding 6 months (90% vs 78%;
P=.04), 1 hypoglycemic-related emergency room visit during
the preceding 6 months (18.7% vs 6.7%; P=.002), and 1
hypoglycemic event requiring assistance by another during the
preceding 6 months (80% vs 57.6%; P ≤.001). CGM hopefuls
also reported significant differences in well-being (P=.009),
hypoglycemic distress (P=.04), and feeling of powerlessness
(P=.04). The study suggested potential benefits for older people
with the use of advanced technology, which is important given
that hypoglycemic unawareness increase with age. A drawback
of the study was that the 2 groups were of unequal sizes: the
user group=11 and the hopeful group=75.
Information Overload and Ease of Use
Borges and Kubiak [39] explored the relationship between
information overload, ease of use, and personal attitude in the
use of CGM by identification of motivations to use CGM and
comparison of characteristics between groups with differing
levels of CGM experience. The findings were that, irrespective
of the level of experience, the advantages of CGM were
perceived as high and the disadvantages perceived as low. There
was a significant difference with respect to perceived
information overload; adults with T1D without experience rated
this higher than adults with T1D with more experience (90%
CI 1.443-0.785; P ≤.001). This is important because information
overload had a negative influence on the ease of use (P ≤.001).
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The study reports statistically significant outcomes; however,
the participants were recruited through Web-based forums and
social media and described as having high levels education,
which was a potential socioeconomic limiting factor.
The Potential of Continuous Glucose Monitoring to
Explore Stressors
Gonder-Frederick et al [30] investigated the relationship between
routine daily stressors, BG levels, and diabetes management
strategies in a naturalistic setting using a CGM data to generate
BG profiles (adults with T1D were also participating in
multicenter cross-over randomized controlled trial closed- loop
control CLC study). There was no relationship found between
stress ratings and average daily glucose. However, stress ratings
were positively related to low BG levels (P=.025). Overall, the
results suggested individual differences between stress and
glycemic control for people with T1D and the potential of CGM
to explore this more in depth. This needs to be countered with
the acknowledged small sample of participants (n=33) and a
short-term study with highly selected participants.
The Relationship Between Diabetes Distress and
Technology
Naranjo et al [38] undertook a comparative analysis of the level
of diabetes distress that is associated with diabetes devices and
technology between users of traditional technology (BG meters
and MDI) and advanced technology (pump therapy and CGM).
The results showed significant differences between attitudes to
technology with CGM users being more positive than nonusers
(24.87 vs 23.87; P ≤.001). Pump users were more positive than
MDI users (24.8 vs 22.98; P ≤.001). There were no significant
differences in distress across all types of technology use by
participants. However, there was no account for confounding
variables other than age.
Ritholz et al [41] qualitatively compared psychosocial
differences between 3 groups of participants who were
participants from the Juvenile Diabetes Research Trial:
responders (n=7), drawn from a primary cohort who had shown
improvement in glycemic control; responders (n=6), drawn
from a secondary cohort who had demonstrated a reduction in
HbA1c in within target range, and nonresponders (n=7), who
had a less than 0.5% reduction in HbA1c. The following themes
emerged from the findings: coping with frustrations, use of
CGM information, significant other information, and body
image. Frustrations were experienced with CGM, CSII,
calibrations, and alarms. Responders reported a self-controlling
coping style whereas nonresponders were more likely to make
an emotional response. All participants were engaged with
minute-to-minute information, but responders were more likely
to use retrospective information to spot trends and act upon
them. Many responders reported significant other involvement,
especially males who suggested that this allayed other important
fears about the risks of hypoglycemia. Body image of use of
the device was associated with “nonresponders,” who felt
uncomfortable about using the device in public places and
intimate situations. The researchers raised the role of “significant
others” in CGM research and suggested that this is an
underexplored area. The research also highlights the clinical
implications of preparation of adults with T1D to deal with
frustrations and cognitive overload.
The limitations of the research are that it was carried out on a
population that was described as well educated and homogenous.
Cognition in the Wild
Some researchers have adopted an ethnographic approach to
explore how technology is used in the context of the everyday
lives of adults with T1D.
O’Kane et al [42] took a sociocultural perspective and reported
on 3 qualitative studies that examined how devices for adults
with T1D are adopted, carried, and used in a variety of everyday
contexts. This is based on the premise that adults with T1D are
encouraged to self-regulate by HCPs, but the nature of everyday
life is contingent upon the dynamics of the unfolding situation.
The following themes emerged from the data analysis: misuse,
inappropriate use, and unintended use of the technology. The
authors’ main point is that any individual can report a wide
variation in normal use of their technology across a continuum
of public use, work-life use, and in the company of friends and
family. This was based on the perceived emotions and attitudes
of the other party within a given context. Uncertainty in discrete
situations can lead to hiding a device, whereas showing off the
device in other situations can lead to normalization and control
of a situation. This corresponds with the findings of Ritholz et
al [41], which were reported in the previous section regarding
the place of significant others in uptake and use of technology.
Meanings, Views, and Perspectives From the Users of
Advanced Technology
Research that examines the meaningfulness and perspectives
of the user has an important role to play in the future and
ongoing development of advanced technology. Shepherd et al
[40] explored both desires and concerns regarding the use of
CGM for self-management. The findings suggested that adults
with T1D who already used insulin pumps and CGM had a
diverse range of attitudes and concerns along a continuum
regarding personalized glucose advisory systems. Participants
would have liked advice from the system on suggestions for
correction boluses, basal rates, insulin-carbohydrate ratios, and
alerts to the risks of hypoglycemia. However, it would be
necessary for the individual to understand how the advice was
generated, trusting that all personal variables would be
considered to develop the confidence to relinquish control to
an automated system. A shortcoming of the study is that it was
not entirely clear how the themes were arrived at.
Lawton et al [44] (2014) found evidence of similar themes
during a longitudinal study of the use of insulin bolus calculators
following the intervention of a dose adjustment for normal eating
course. Adults with T1D were motivated by the device because
it saved time and effort in calculations; however, those who
were confident in their mathematical ability undertook their
own individual calculations and were paradoxically less likely
to use the device over time. Reliance on the calculator alone
had a detrimental impact on glycemic control. Some participants
left the ratios unchanged until their next clinician/study review,
and for some, this was attributed to not knowing how to change
the settings. Underconfidence in carrying out personal
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calculations or not knowing how to change settings led to loss
of trust in the technology.
Storni [43] contends that diabetes is more than a disease and
should be regarded as a complex lifestyle. People with T1D
develop lay expertise that is unique to their situation. This
creates implications for technology design, and it is crucial to
involve the user in the process. This perspective is based upon
findings that emerged from an ethnographic study on diabetes
support groups and by following individuals with T1D within
the context of their everyday lives [43]. The purpose was to
examine what participants really did in dealing with their
condition as opposed to what they were told to do by clinicians.
These findings influenced the design of a tagging system for
events from everyday life to link them to carbohydrate intake
and BG readings to create meaning between the events and a
log for the individual on a mobile device. A shortcoming of the
study is that the report provided a lack of demographic
information about participants, which is important in qualitative
research to determine transferability to other contexts.
Nevertheless, there is an emergent field of research that
addresses the diverse needs of people with T1D in the design
of technologies.
Discussion
Principal Findings
Advanced technology for the management of T1D needs to have
clear benefits that are meaningful to adults with T1D. The aim
of the review was to describe the relationship between human
factors and adherence with technology for data logging processes
in adults with T1D and to explore the factors that influence this
association.
There was inconclusive evidence about the relationship between
adherence to data logging and measurable outcomes in relation
to the review question. However, clinical values may have less
importance than perceived outcomes for individuals. The review
did suggest increased satisfaction with treatment on transition
to advanced technology; however, this was biased toward
frequent users of existing technologies and with an acceptance
of the time required to spend on diabetes care.
The review also showed some benefits of advanced technology
for older people by mediating complexities and fear of
hypoglycemia. There appears to be a wide variation in the
normal use of technology for adults with T1D across a
continuum of sociocultural contexts. There is also a variability
regarding user involvement in the design of future technologies
and the role of “significant others” and this requires further
research. People need to be able to trust technology as the
capacity for intelligent decision-making advances.
In the literature that was reviewed, participants appeared to be
a highly selective group biased toward white populations.
Another limitation was the relatively small sample sizes of some
of the quantitative studies included within the review, only 1
study [35] reporting on a power calculation, thus making it hard
to generalize the findings.
A significant issue was that where demographic characteristics
were reported (Table 1), 95% of the participants were described
as white. The data suggest that those from higher socioeconomic
groups are more likely to have access to and engage with
technology in their self-management behaviors [38]. Of the
studies, 2 [30,45] purposefully selected participants with prior
adherent behaviors; however, 1 study recruited participants who
were less engaged with technology and adherence [32].
The predominance of white participants, combined with the fact
that 6 of the reviewed studies were samples drawn from parent
clinical trials, suggests that the data are based on a highly
selective group. This may not be representative of the general
adult population with T1D. The mean baseline HbA1c of 7.9
implies that participants had relatively good control before
entering one of the respective studies, which may suggest a
largely adherent sample.
Although qualitative research is not considered to be necessarily
generalizable by some audiences [47], it is incumbent on the
researcher to provide full demographic descriptions so that the
generic reader from an interdisciplinary audience can decide
about the transferability of findings to his or her own practice,
research, or development context. Furthermore, trustworthiness
of the findings can be clarified based on participants’ checking
of data and peer review of data analysis. This was a shortcoming
of some of the literature that was reviewed.
Implications for Health Care Practice
Engaged participants spend considerable time on diabetes care,
so it is important that they receive support to make informed
choices. On the basis of this review, it was found that these are
the people most likely to benefit from the affordances of
advanced technology; however, this creates a tension between
these populations and hard-to-reach groups who may be at
increased risk of diabetes complications. Furthermore, Lawton
et al [44] suggest that in general HCPs lack knowledge about
the scope and purpose of advanced technology for diabetes.
This is important, given the potential information overload and
the frustrations that adults with T1D are presented with when
using technology demonstrated within this review and other
literature [9,19,41].
What is meaningful for the adult with T1D might not be
important for the clinician and may therefore require mediation.
Storni [43] found that patient-generated tags for mobile devices
developed by participants were not of interest to clinicians who
were more focused on numerical values.
James et al [47] have explored the perceptions and experiences
of diabetes educators when supporting the use of advanced
technology and suggest that there are challenges for all parties.
This includes device costs, access to Wi-Fi, and appropriate
mobile devices. CSII puts demands on diabetes services, and
there are also challenges associated with keeping up to date with
technology, such as the skills to analyze data from patient mobile
devices. This research study suggested that there is a need for
mentorship of HCPs and a review of service configurations as
technology advances.
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Implications for Future Design of Technologies
Engaging people in the design of technology for T1D is essential
for meeting the requirements of the user. Within this review,
O’Kane et al [42] suggested that the design of devices needs to
be both discrete and more public for context-dependent behavior.
Lawton et al [44] suggested that voice recognition for entering
data would make data logging practices easier for some people.
Engaged participants appeared to be able to deal with the hassle
and time required for diabetes-related tasks. However, a
challenge for designers is to build in time-efficient capabilities.
Implications for Future Research
There is a requirement for studies within the context of
day-to-day data logging that are representative of the general
adult population with T1D. There is more scope for research
that explores how technology could be used to engage
hard-to-reach groups. Many of the studies in this review were
short-term; however, the study undertaken by Lawton et al [44]
on the use of insulin bolus calculators was in-depth and over
time (1 year), thus providing a rich and diverse view of
adherence and nonadherence along a trajectory, which provided
important nuances about human factors. There is also a need to
study the role of significant others within data logging processes
[41]. There appeared to be a dearth of mixed-methods studies,
which if conducted through a rigorous methodological process
have the potential to capture the complexity of human factors
by maximizing the advantages of more than one research design.
There is also a need for future studies that explore the
sociocultural and demographic factors associated with
technology uptake.
Limitations
A limitation of this review is that the data were drawn from
databases, which excludes emergent unpublished research in a
fast-moving field. However, this was mitigated by extracting
the data from sources retrieved from 9 key databases covering
the fields of health, medicine, and computer science, and the
search was performed in collaboration with a university health
care librarian.
Comparison With Prior Work
The application of critical appraisal frameworks used in this
review made it possible to evaluate the reliability, validity, and
trustworthiness of each of the studies under consideration. This
review presents a contribution to the field in comparison with
descriptive mapping reviews and highlights areas where research
design could be improved. By abstracting data from each of the
studies, it was possible to compare the findings and focus on
the human factor constructs of adult populations with T1D,
including older people.
Conclusions
The purpose of this systematic review was to explore the
relationship between human factors and the adherence to
technology for data logging in adults with T1D. The research
design was an integrative review, given the interdisciplinary
nature of research in the field and the diverse methodological
approaches taken to inquiries.
The aim of the review was to analyze the relationship between
human factors and adherence to technology for data logging in
adults with T1D. Overall, the sample was drawn from
homogeneous populations that may not be the complete
representation of adults with T1D. Inconclusive evidence was
found about the relationship between adherence to data logging
with advanced technology and measurable outcomes. There
was some suggestion that adults with T1D may feel more
satisfied with their treatments on transition to advanced
technology. Qualitative research suggested that the way in which
technology is used by any individual varies along a continuum
and is contingent upon the sociocultural context in which
technology is used. As technology continues to advance, there
is a need for more research into how trusting the individual is
of personal treatment advice, which is generated through
advanced technology.
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